Ms. Toni Rinow reports
PIVOT RESPONDS TO STOCKWATCH ARTICLE ON NOTICE OF CLAIM FILED BY ALY ISMAIL
Pivot Pharmaceuticals Inc. is responding to the Stockwatch article dated Sept. 18, 2019, regarding the claims filed by Aly Ismail/Green Stream Botanicals Corp. As of the date hereof, Pivot has not been served with the claim and Pivot strongly denies all allegations contained in the article and the claims by Aly Ismail as described in the article are without merit.
Pivot further notes that neither Mr. Ismail nor Green Stream Botanicals Corp. nor NH Transcendental Solutions Inc. are registrants under Canadian securities laws and thus any claim by Mr. Ismail with respect to a finder's fee in connection with a private placement without the appropriate registration or exemption would constitute a breach by Mr. Ismail of Canadian securities laws. Pivot intends to vigorously defend the claim, if as and when served by Mr. Ismail. Pivot urges the regulators to sanction unregistered non-exempt persons that are engaging in activities such as those allegedly engaged by Mr. Ismail that would be in violation of applicable securities laws.
About Pivot Pharmaceuticals Inc.
Pivot Pharmaceuticals is a science-based, consumer packaged goods cannabis company engaged in the development and commercialization of health and wellness products using innovative, patent-protected drug delivery technologies.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.